{
  "DOI": "10.1007/s10689-015-9819-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-015-9819-7",
  "alternative-id": [
    "9819"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Spinelli",
      "given": "Claudio",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Strambi",
      "given": "Silvia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Piccini",
      "given": "Lorenzo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rossi",
      "given": "Leonardo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Aretini",
      "given": "Paolo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Caligo",
      "given": "Adelaide",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2015,
        6,
        17
      ]
    ],
    "date-time": "2015-06-17T08:21:25Z",
    "timestamp": 1434529285000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:16Z",
    "timestamp": 1559252776000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        4,
        1
      ]
    ],
    "date-time": "2022-04-01T20:03:50Z",
    "timestamp": 1648843430757
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2015,
        6,
        18
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2015,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2015,
            6,
            18
          ]
        ],
        "date-time": "2015-06-18T00:00:00Z",
        "timestamp": 1434585600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9819-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-015-9819-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9819-7",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "515-519",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2015,
        6,
        18
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2015,
        6,
        18
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2015,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.ejphar.2013.03.037",
      "author": "B Sousa",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "issue": "1–3",
      "journal-title": "Eur J Pharmacol",
      "key": "9819_CR1",
      "unstructured": "Sousa B, Moser E, Cardoso F (2013) An update on male breast cancer and future directions for research and treatment. Eur J Pharmacol 717(1–3):71–83",
      "volume": "717",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10549-008-0162-7",
      "author": "M Wasielewski",
      "doi-asserted-by": "crossref",
      "first-page": "397",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9819_CR2",
      "unstructured": "Wasielewski M, den Bakker MA, van den Ouweland A et al (2009) CHEK2 1100delC and male breast cancer in the Netherlands. Breast Cancer Res Treat 116(2):397–400",
      "volume": "116",
      "year": "2009"
    },
    {
      "DOI": "10.1002/ijc.11603",
      "author": "T Ohayon",
      "doi-asserted-by": "crossref",
      "first-page": "479",
      "issue": "3",
      "journal-title": "Int J Cancer",
      "key": "9819_CR3",
      "unstructured": "Ohayon T, Gal I, Baruch RG et al (2004) CHEK2 1100delC and male breast cancer risk in Israel. Int J Cancer 108(3):479–480",
      "volume": "108",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10549-011-1842-2",
      "author": "A Blanco",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9819_CR4",
      "unstructured": "Blanco A, de la Hoya M, Balmana J et al (2012) Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer. Breast Cancer Res Treat 132(1):307–315",
      "volume": "132",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.bjc.6690663",
      "author": "IE Young",
      "doi-asserted-by": "crossref",
      "first-page": "141",
      "issue": "1",
      "journal-title": "Br J Cancer",
      "key": "9819_CR5",
      "unstructured": "Young IE, Kurian KM, Annik C et al (1999) A polymorphism in the CYP17 gene is associate with male breast cancer. Br J Cancer 81(1):141–143",
      "volume": "81",
      "year": "1999"
    },
    {
      "DOI": "10.1186/1471-2407-8-146",
      "author": "P Katri",
      "doi-asserted-by": "crossref",
      "first-page": "146",
      "journal-title": "BMC Cancer",
      "key": "9819_CR6",
      "unstructured": "Katri P, Hannele E, Jenni N, Szilvia S, Robert W (2008) Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families. BMC Cancer 8:146",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1186/1471-2407-13-243",
      "author": "P Blay",
      "doi-asserted-by": "crossref",
      "first-page": "243",
      "journal-title": "BMC Cancer",
      "key": "9819_CR7",
      "unstructured": "Blay P, Santamaría I, Pitiot AS, Luque M, Alvarado MG, Lastra A et al (2013) Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain). BMC Cancer 13:243",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.20.6.1480",
      "author": "TS Frank",
      "doi-asserted-by": "crossref",
      "first-page": "1480",
      "journal-title": "J Clin Oncol",
      "key": "9819_CR8",
      "unstructured": "Frank TS, Deffendaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.2131/jts.38.355",
      "author": "JK Hyo",
      "doi-asserted-by": "crossref",
      "first-page": "355",
      "issue": "3",
      "journal-title": "J Toxicol Sci",
      "key": "9819_CR9",
      "unstructured": "Hyo JK, Young BH, Yong WY, Chi-Heum C, Antai W, Insoo B (2013) The correlations between BRCA1 defect and environmental factors in the risk of breast cancer. J Toxicol Sci 38(3):355–361",
      "volume": "38",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10689-013-9647-6",
      "author": "B Bielinska",
      "doi-asserted-by": "crossref",
      "first-page": "691",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "9819_CR10",
      "unstructured": "Bielinska B, Gaj P, Kluska A, Nowakowska D, Balabas A et al (2013) Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer. Fam Cancer 12(4):691–698",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-3546",
      "author": "G Chenevix-Trench",
      "doi-asserted-by": "crossref",
      "first-page": "2019",
      "issue": "4",
      "journal-title": "Cancer Res",
      "key": "9819_CR11",
      "unstructured": "Chenevix-Trench G, Healey S, Lakhani S et al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66(4):2019–2027",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1086/521032",
      "author": "DF Easton",
      "doi-asserted-by": "crossref",
      "first-page": "873",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "9819_CR12",
      "unstructured": "Easton DF, Deffenbaugh AM, Pruss D et al (2007) A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81(5):873–883",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-1241",
      "author": "T Judkins",
      "doi-asserted-by": "crossref",
      "first-page": "10096",
      "issue": "21",
      "journal-title": "Cancer Res",
      "key": "9819_CR13",
      "unstructured": "Judkins T, Hendrickson BC, Deffenbaugh AM (2005) Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. Cancer Res 65(21):10096–10103",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.3322/caac.20006",
      "author": "A Jemal",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "journal-title": "CA Cancer J Clin",
      "key": "9819_CR14",
      "unstructured": "Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249",
      "volume": "59",
      "year": "2009"
    },
    {
      "DOI": "10.1245/ASO.2004.01.001",
      "author": "NC Hodgson",
      "doi-asserted-by": "crossref",
      "first-page": "751",
      "issue": "8",
      "journal-title": "Ann Surg Oncol",
      "key": "9819_CR15",
      "unstructured": "Hodgson NC, Button JH, Franceschi D et al (2004) Male breast cancer: is the incidence increasing? Ann Surg Oncol 11(8):751–755",
      "volume": "11",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10549-008-0053-y",
      "author": "V Speirs",
      "doi-asserted-by": "crossref",
      "first-page": "429",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9819_CR16",
      "unstructured": "Speirs V, Shaaban AM (2009) The rising incidence of male breast cancer. Breast Cancer Res Treat 115(2):429–430",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.1186/bcr2930",
      "author": "J White",
      "doi-asserted-by": "crossref",
      "first-page": "219",
      "issue": "5",
      "journal-title": "Breast Cancer Res",
      "key": "9819_CR17",
      "unstructured": "White J, Kearins O, Dodwell D et al (2011) Male breast carcinoma: increased awareness needed. Breast Cancer Res 13(5):219",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1093/annonc/mdt025",
      "author": "KJ Ruddy",
      "doi-asserted-by": "crossref",
      "first-page": "1434",
      "issue": "6",
      "journal-title": "Ann Oncol",
      "key": "9819_CR18",
      "unstructured": "Ruddy KJ, Winer EP (2013) Male Breast Cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 24(6):1434–1443",
      "volume": "24",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S0140-6736(06)68226-3",
      "author": "IS Fentiman",
      "doi-asserted-by": "crossref",
      "first-page": "595",
      "journal-title": "Lancet",
      "key": "9819_CR19",
      "unstructured": "Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595–604",
      "volume": "367",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10549-007-9689-2",
      "author": "M Falchetti",
      "doi-asserted-by": "crossref",
      "first-page": "161",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9819_CR20",
      "unstructured": "Falchetti M, Lupi R, Rizzolo P et al (2008) BRCA1/BRCA2 rearragements and CHEK 2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat 110(1):161–167",
      "volume": "110",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10549-012-2062-0",
      "author": "L Ottini",
      "doi-asserted-by": "crossref",
      "first-page": "411",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9819_CR21",
      "unstructured": "Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M et al (2012) Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy. Breast Cancer Res Treat 134(1):411–418",
      "volume": "134",
      "year": "2012"
    },
    {
      "DOI": "10.1186/bcr3463",
      "author": "S Deb",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "journal-title": "Breast Cancer Res",
      "key": "9819_CR22",
      "unstructured": "Deb S, Do H, Byrne D, Jene N, kConFab Investigators, Dobrovic A, Fox SB (2013) PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer. Breast Cancer Res 15:69",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1093/jnci/djm203",
      "author": "YC Tai",
      "doi-asserted-by": "crossref",
      "first-page": "1811",
      "issue": "23",
      "journal-title": "J Natl Cancer Inst",
      "key": "9819_CR23",
      "unstructured": "Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811–1814",
      "volume": "99",
      "year": "2007"
    },
    {
      "author": "E Kwiatkowska",
      "first-page": "4452",
      "journal-title": "Clin Cancer Res",
      "key": "9819_CR24",
      "unstructured": "Kwiatkowska E, Teresiak M, Filas V et al (2003) BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clin Cancer Res 9:4452–4459",
      "volume": "9",
      "year": "2003"
    },
    {
      "DOI": "10.1093/nar/gkt231",
      "author": "L Young-Ho",
      "doi-asserted-by": "crossref",
      "first-page": "5784",
      "issue": "11",
      "journal-title": "Nucleic Acids Res",
      "key": "9819_CR25",
      "unstructured": "Young-Ho L, Ching-Ying K, Jeremy MS, David KA et al (2013) HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response. Nucleic Acids Res 41(11):5784–5798",
      "volume": "41",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ccr.2013.03.025",
      "author": "M Li",
      "doi-asserted-by": "crossref",
      "first-page": "693",
      "issue": "5",
      "journal-title": "Cancer Cell",
      "key": "9819_CR26",
      "unstructured": "Li M, Yu X (2013) Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell 23(5):693–704",
      "volume": "23",
      "year": "2013"
    },
    {
      "DOI": "10.1038/pcan.2013.12",
      "author": "P Luca De",
      "doi-asserted-by": "crossref",
      "first-page": "233",
      "issue": "3",
      "journal-title": "Prostate Cancer Prostatic Dis",
      "key": "9819_CR27",
      "unstructured": "De Luca P, Moiola CP, Zalazar F, Gardner K, Vazquez ES (2013) BRCA1 and p53 regulate critical prostate cancer pathways. Prostate Cancer Prostatic Dis 16(3):233–238",
      "volume": "16",
      "year": "2013"
    },
    {
      "DOI": "10.1038/sj.bjc.6603535",
      "author": "E Levy-Lahad",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "issue": "1",
      "journal-title": "Br J Cancer",
      "key": "9819_CR28",
      "unstructured": "Levy-Lahad E, Friedman E (2007) Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 96(1):11–15",
      "volume": "96",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.clon.2010.11.007",
      "author": "SA Han",
      "doi-asserted-by": "crossref",
      "first-page": "434",
      "issue": "7",
      "journal-title": "Clinical Oncology",
      "key": "9819_CR29",
      "unstructured": "Han SA, Park SK, Ahn SH et al (2011) The Korean Hereditary Breast Cancer (KOHBRA) Study: protocols and Interim Report. Clinical Oncology 23(7):434–441",
      "volume": "23",
      "year": "2011"
    },
    {
      "author": "L Fiala",
      "first-page": "612",
      "issue": "10",
      "journal-title": "Rozhl Chir",
      "key": "9819_CR30",
      "unstructured": "Fiala L, Coufal O, Fait V, Foretová L (2010) Male breast cancer–our experience. Rozhl Chir 89(10):612–618",
      "volume": "89",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.breast.2013.07.053",
      "author": "L Varesco",
      "doi-asserted-by": "crossref",
      "first-page": "1130",
      "issue": "6",
      "journal-title": "The Breast",
      "key": "9819_CR31",
      "unstructured": "Varesco L, Viassolo V, Viel A et al (2013) Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: a retrospective study in a sample of Italian cancer genetics clinics. The Breast 22(6):1130–1135",
      "volume": "22",
      "year": "2013"
    },
    {
      "author": "K Kast",
      "journal-title": "Int J Cancer",
      "key": "9819_CR32",
      "unstructured": "Kast K, Schmutzler RK, Rhiem K et al (2014) Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer. Int J Cancer. doi: 10.1002/ijc.28875",
      "year": "2014"
    },
    {
      "DOI": "10.1002/humu.22150",
      "author": "GA Millot",
      "doi-asserted-by": "crossref",
      "first-page": "1526",
      "issue": "11",
      "journal-title": "Hum Mutat",
      "key": "9819_CR33",
      "unstructured": "Millot GA, Carvalho MA, Caputo SM et al (2012) A guide for functional analysis of BRCA1 variants of uncertain significance. Hum Mutat 33(11):1526–1537",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1128/MCB.01075-08",
      "author": "L Wei",
      "doi-asserted-by": "crossref",
      "first-page": "7380",
      "journal-title": "Mol Cell Biol",
      "key": "9819_CR34",
      "unstructured": "Wei L, Lan L, Hong Z et al (2008) Rapid recruitment of BRCA1 to DNA double-strand breaks is dependent on its association with Ku80. Mol Cell Biol 24:7380–7393",
      "volume": "24",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.22251",
      "author": "WI Towler",
      "doi-asserted-by": "crossref",
      "first-page": "439",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "9819_CR35",
      "unstructured": "Towler WI, Zhang J, Ransburgh DJ et al (2013) Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing. Hum Mutat 34(3):439–445",
      "volume": "34",
      "year": "2013"
    }
  ],
  "reference-count": 35,
  "references-count": 35,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-015-9819-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}